PYRIMIDINE-FUSED RING COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF

WIPO Patent Application WO/2024/061370

A1

Disclosed in the present invention is a pyrimidine-fused ring compound having an inhibitory effect on KRAS gene mutation, or a pharmaceutically acceptable salt, stereoisomer or solvate thereof. In addition, further disclosed in the present invention are a pharmaceutical composition containing the compound, and the use thereof in the preparation of cancer drugs.

JPS5646866	6*77SECOERGOLINE DERIVATIVE* ITS MANUFACTURE PHARMACEUTICAL COMPOSITION CONTAINING IT AND HAVING ALPHAAADRENALIN INTERRUPTING* HYPOTENSIVE* CETRAL NERVE STIMULATING AND*OR INHIBITING AND DOPAMINE ACTI
JP2828091	TRICYCLIC COMPOUND PRODUCING MICROORGANISM
JP6297274	Heterocyclic compounds, organic light emitting devices and organic light emitting display devices

JIANG TAO (CN)
ZHOU FUSHENG (CN)
LIANG TAO (CN)
LIN CHONGLAN (CN)
CAI LIJIAN (CN)
LIU ZHUBO (CN)
XU XIAOMING (CN)
MA KAI (CN)
ZHANG LEITAO (CN)
LI ZHEN (CN)
LAN JIONG (CN)

PCT/CN2023/121172

March 28, 2024

September 25, 2023

Click for automatic bibliography generation  

GENFLEET THERAPEUTICS SHANGHAI INC (CN)
ZHEJIANG GENFLEET THERAPEUTICS CO LTD (CN)

C07D498/14; A61K31/4985; A61K31/506; A61K31/519; A61K31/5377; A61K31/553; A61P35/00; C07D471/14; C07D498/22; C07D519/00

WO2022173678A1	2022-08-18
WO2022188729A1	2022-09-15
WO2022194245A1	2022-09-22
WO2023030385A1	2023-03-09
WO2022199587A1	2022-09-29
WO2022206723A1	2022-10-06
WO2022268051A1	2022-12-29
WO2023274383A1	2023-01-05
WO2023001123A1	2023-01-26
WO2023001141A1	2023-01-26

MERITS IP LTD. (CN)

View/Download PDF      PDF Help

Previous Patent: COMPOSITION AND METHODS OF AGING-RELATED AGENT SCREENING AND TARGET ANALYSIS

Next Patent: ANNELATED PYRIDINE STEROID SYNTHETASE INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF